Single center experience of 90Y-Ibritumomab tiuxetan in the older population with non-hodgkin lymphoma.

被引:0
作者
Agrawal, Vaibhav [1 ]
Castillo, Jose Isaac [1 ]
Raup, Kelly [1 ]
Girton, Treanna [1 ]
Collins, Scott R. [1 ]
Brady, James O. [1 ]
Khan, Sharif S. [1 ]
Vadakara, Joseph [1 ]
机构
[1] Geisinger Med Ctr, Danville, PA 17822 USA
关键词
D O I
10.1200/JCO.2016.34.15_suppl.e19035
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e19035
引用
收藏
页数:2
相关论文
共 50 条
[31]   RIT with Y-90-Ibritumomab Tiuxetan in Follicular Non-Hodgkin Lymphoma: Evaluation of Recent Outcomes in a Single Institution [J].
Miguel, Marcio ;
Campos, Andrade ;
Limon, Anel E. Montes ;
Grasa, Jose Maria ;
Lievano, Paola ;
Baringo, Teresa ;
Giraldo, Pilar .
JOURNAL OF ONCOLOGY, 2012, 2012
[32]   90Y-ibritumomab treatment for relapsed and/or refractory B cell type non-hodgkin's lymphoma.: Multiinstitutional Argentinian study [J].
Cacchione, Roberto ;
Dupont, Juan ;
Milone, Jorge ;
Bordone, Javier ;
Garay, Guy ;
Ardaiz, Maria ;
Castro-Rios, Miguel ;
Prates, Virginia ;
Basso, Alfredo ;
Labstrebner, Marcelo ;
Avila, Graciela ;
Diaz, Alicia ;
Argentieri, Daniel ;
Rudoy, Silvia ;
Trouboul, Alicia ;
Palmer, Luis ;
Pombo, Gonzalo ;
Rappaciotti, Silvina ;
Negri, Pedro ;
Lafalse, Diana ;
Riera, Leandro ;
de Tezanos-Pinto, Miguel ;
Riveros, Dardo ;
Arnold, Mario Brown ;
Carrasco, Antonio ;
Bezares, Fernando .
BLOOD, 2007, 110 (11) :192B-192B
[33]   90Y-ibritumomab treatment for relapsed and/or refractory B cell type non-Hodgkin's lymphoma.: Multiinstitutional Argentinian study [J].
Cacchione, R. ;
Dupont, J. ;
Milone, J. ;
Bordone, J. ;
Riera, L. ;
Ardaiz, M. ;
Castro-Rios, M. ;
Iabstrebner, M. ;
Pombo, G. ;
Basso, A. ;
Avila, G. ;
Rodriguez, S. ;
Tartas, N. ;
Plana, J. ;
Garay, G. ;
Riveros, D. ;
Carrasco, A. ;
Bezares, F. .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 :111-111
[34]   Efficacy and safety of 90Y ibritumomab tiuxetan (Zevalin) radioimmunotherapy for non-Hodgkin's lymphoma [J].
Witzig, TE .
SEMINARS IN ONCOLOGY, 2003, 30 (06) :11-16
[35]   Safety and efficacy of yttrium-90 ibritumomab tiuxetan in older patients with non-hodgkin's lymphoma [J].
Emmanouilides, Christos ;
Witzig, Thomas E. ;
Wiseman, Gregory A. ;
Gordon, Leo I. ;
Wang, Hua ;
Schilder, Russell ;
Saville, M. Wayne ;
Flinn, Ian ;
Molina, Arturo .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2007, 22 (05) :684-691
[36]   90Y-ibritumomab tiuxetan (Zevalin®) consolidation in non-Hodgkin's B lymphoma: severe haematological toxicity reported in two Mantle patients [J].
Pena, F. J. ;
Crespo-Jara, A. ;
Sureda, M. ;
Redal, M. C. ;
Garcia-Cases, F. ;
Rebello, J. ;
Fernandez, P. L. ;
Evgenyeva, E. ;
Brugarolas, A. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 :S149-S149
[37]   RIT with 90Y Ibritumomab Tiuxetan in Patients with Non-Hodgkin Lymphoma Over 65 Years [J].
Andrade, Marcio M., Sr. ;
Montes, Anel ;
Murillo, Ilda ;
Grasa, Jose M., Sr. ;
Baringo, Teresa ;
Giraldo, Pilar .
BLOOD, 2012, 120 (21)
[38]   Ibritumomab tiuxetan (Zevalin) for non-Hodgkin's lymphoma [J].
不详 .
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2002, 44 (1144) :101-102
[39]   Radioimmunotherapy for NHL:: Experience of 90Y-ibritumomab tiuxetan in clinical practice [J].
Hagenbeek, A .
LEUKEMIA & LYMPHOMA, 2003, 44 :S37-S47
[40]   Radioimmunotherapy with 90Y-ibritumomab tiuxetan (Zevalin) in treatment of CD 20 positive mature B-cell non-Hodgkin's lymphoma: Initial experience. [J].
Khan, H. A. K. ;
Shemmari, S. A. S. ;
Sajnani, K. S. ;
Mohannadi, S. A. M. ;
Huda, F. A. H. ;
Usmani, S. U. ;
Abdulla, M. M. A. ;
Mahmoud, S. A. D. ;
Javaid, A. J. ;
Sahi, Z. M. S. ;
Wael, W. A. ;
Ghaniem, I. G. ;
Parekh, H. G. P. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 :S168-S168